MENU
+Compare
SOPH
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$4.31
Change
-$0.13 (-2.93%)
Capitalization
291.27M

SOPH SOPHiA GENETICS SA Forecast, Technical & Fundamental Analysis

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research... Show more

SOPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SOPH with price predictions
Oct 17, 2025

SOPH in +6.19% Uptrend, growing for three consecutive days on October 15, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SOPH advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where SOPH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

SOPH moved above its 50-day moving average on September 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SOPH crossed bullishly above the 50-day moving average on September 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SOPH moved out of overbought territory on October 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator moved out of overbought territory. In of the 13 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SOPH as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SOPH turned negative on October 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOPH broke above its upper Bollinger Band on September 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.912) is normal, around the industry mean (21.732). P/E Ratio (0.000) is within average values for comparable stocks, (83.279). SOPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.618). SOPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (4.255) is also within normal values, averaging (70.594).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SOPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SOPH is expected to report earnings to fall 31.52% to -22 cents per share on November 11

SOPHiA GENETICS SA SOPH Stock Earnings Reports
Q3'25
Est.
$-0.23
Q2'25
Missed
by $0.11
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.06
The last earnings report on August 05 showed earnings per share of -33 cents, missing the estimate of -21 cents. With 79.71K shares outstanding, the current market capitalization sits at 291.27M.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
La Pièce 12
Phone
+41 216941060
Employees
449
Web
https://www.sophiagenetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNMSF13.610.03
+0.22%
SPIN MASTER CORP
LEKOF0.01N/A
N/A
Lekoil Ltd
HLBBF7.21N/A
N/A
H. Lundbeck A/S
GFLT10.43N/A
N/A
GenFlat Holdings, Inc.
VLVLY26.36-1.80
-6.39%
Volvo AB

SOPH and Stocks

Correlation & Price change

A.I.dvisor tells us that SOPH and RIOT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SOPH and RIOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
-2.93%
RIOT - SOPH
32%
Poorly correlated
+2.46%
COIN - SOPH
30%
Poorly correlated
+1.75%
GMGI - SOPH
29%
Poorly correlated
-0.86%
PSFE - SOPH
28%
Poorly correlated
+1.52%
TIXT - SOPH
27%
Poorly correlated
-0.44%
More

Groups containing SOPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
-2.93%
Health Services
category (427 stocks)
4%
Poorly correlated
-1.10%
Services to the Health Industry
category (93 stocks)
4%
Poorly correlated
-2.28%